xmlui.dri2xhtml.METS-1.0.item-contributor-funder:
Ministerio de Economía y Competitividad (España) Ministerio de Ciencia, Innovación y Universidades (España) Comunidad de Madrid
Sponsor:
The author gratefully acknowledges the support from the Ministerio de Economìa y Competitividad (Spain) (ECO2015-68615-P), Marìa de Maeztu grant (MDM 2014-0431), from Comunidad de Madrid, MadEco-CM (S2015/HUM-3444), and from the Ministerio de Ciencia, Innovación y Universidades (FJCI-2016-28864 and IJC2018-038229-I)
Project:
Gobierno de España. MDM-2014-0431 Comunidad de Madrid. S2015/HUM-3444 Gobierno de España. ECO2015-68615-P Gobierno de España. IJC2018-038229-I
Keywords:
Human capital
,
Output
,
Labor productivity
,
Hiv/Aids
We develop a general equilibrium model to study the impact of HIV/AIDS on human capital accumulation decisions and on aggregate output. We calibrate the model targeting a sample of Sub-Saharan African countries, separately for 1995-2004 and 2010-2017. Our resuWe develop a general equilibrium model to study the impact of HIV/AIDS on human capital accumulation decisions and on aggregate output. We calibrate the model targeting a sample of Sub-Saharan African countries, separately for 1995-2004 and 2010-2017. Our results show that the scale-up of ART treatments since mid-2000s, and the additional reductions in the transmission rate have had a significant impact on output. Counterfactual exercises suggest significant output gains from further increasing ART treatment and decreasing infectiousness. The output gains are substantially larger than the costs. We find that treatment and policies that reduce infection (e.g. condom use) are substitutes.[+][-]